Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Protocols|December 6, 2023
Head-mounted central venous access during optical recordings and manipulations of neural activity in miceChristine Liu, Daniel J Freeman, Stephan Lammel
The Journal of Biological Chemistry|April 20, 2004
PTEN regulates Mdm2 expression through the P1 promoterChun-Ju Chang, Daniel J Freeman, Hong Wu
Nature Reviews. Drug Discovery|July 12, 2019
Optimizing oncolytic virotherapy in cancer treatmentKevin Harrington, Daniel J Freeman, Beth Kelly, et al.
Neoplasia (New York, N.Y.)|February 27, 2013
Gene expression profiles can predict panitumumab monotherapy responsiveness in human tumor xenograft modelsMichael J Boedigheimer, Daniel J Freeman, Panteha Kiaei, et al.
Molecular Cancer Therapeutics|June 11, 2009
Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptorDaniel J Freeman, Tammy Bush, Selam Ogbagabriel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2008
Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancerTim J Kruser, Eric A Armstrong, Amol J Ghia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
A phase 2 randomized trial of paclitaxel and carboplatin with or without panitumumab for first-line treatment of advanced non-small-cell lung cancerJeffrey Crawford, Paul Swanson, Paul Schwarzenberger, et al.
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
Diagnostic Pathology|April 20, 2010
A comparability study of 5 commercial KRAS testsKelly Oliner, Todd Juan, Sid Suggs, et al.
Molecular Cancer|July 27, 2012
Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancerDaniel J Freeman, Kevin McDorman, Selam Ogbagabriel, et al.
Pageof 2